DAYLI Partners
Overview
DAYLI Partners is a venture capital firm in South Korea that specializes in venture investments in the pharmaceutical, healthcare, and biotechnology sectors . The firm creates sustainable value by spearheading industry evolution and innovation .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Doctor Now | Sep 2025 | Series B Extension | Co-investor |
| Illimis Therapeutics | Jul 2025 | Series B | Co-investor |
| HysensBio | May 2019 | Series B | Co-investor |
| HMC Networks | Jul 2022 | Debt | Co-investor |
| Carenation | Jul 2022 | Debt | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is DAYLI Partners based?
DAYLI Partners is headquartered in Seoul, Seoul, South Korea.
When was DAYLI Partners founded?
DAYLI Partners was founded in 2014.
How many portfolio companies does DAYLI Partners have?
DAYLI Partners has 41 portfolio companies in Caplight's dataset.
What are some companies in DAYLI Partners's portfolio?
Portfolio companies visible on Caplight include Doctor Now, Illimis Therapeutics, HysensBio, HMC Networks, Carenation.
What was DAYLI Partners's most recent investment shown here?
DAYLI Partners's most recent investment in this portfolio sample was in Doctor Now in 2025.
What sectors does DAYLI Partners focus on?
DAYLI Partners focuses on Enterprise Software, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Enterprise Software, Consumer & Commerce, Frontier & Industrial Tech, Consumer & Commerce, Energy & Sustainability, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Enterprise Software, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Enterprise Software, FinTech, Consumer & Commerce, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Consumer & Commerce, Enterprise Software.
What company stages does DAYLI Partners focus on?
DAYLI Partners typically invests at the Early stage.
What is DAYLI Partners's AUM?
DAYLI Partners's assets under management are estimated between $100.0M and $250.0M.